Patient who are known to be serologically positive for human immunodeficiency virus (HIV)
Patients who have a history of and are known to be serologically positive for human immunodeficiency virus (HIV) and are receiving antiviral therapy; baseline testing is not required
Immunocompromised patients, e.g., patients who are known to be serologically positive for human immunodeficiency virus (HIV) and are receiving antiviral therapy (testing is not part of the protocol)
Patients who are serologically positive for human immunodeficiency virus (HIV)
Serologically positive for HIV; serologically positive for Hepatitis B or Hepatitis C with evidence of liver dysfunction or documented liver cirrhosis
Patients who are known to be serologically positive for human immunodeficiency virus (HIV). This includes HIV patients on antiretroviral therapy due to the potential for pharmacokinetic interactions with olaparib
Immunocompromised subjects, e.g., subjects who are known to be serologically positive for human immunodeficiency virus (HIV).
Patients who are known to be serologically positive for human immunodeficiency virus (HIV)
Immunocompromised patients, e.g. patients known to be serologically positive for HIV. Patients do NOT need to be tested for HIV in order to enroll on study
Immunocompromised patients, e.g., patients who are known to be serologically positive for human immunodeficiency virus (HIV)
Immunocompromised patients, e.g., patients who are known to be serologically positive for human immunodeficiency virus (HIV).
Immunocompromised patients, e.g., patients who are known to be serologically positive for human immunodeficiency virus (HIV)
Patients who are known to be serologically positive for human immunodeficiency virus (HIV).
Known to be serologically positive for human immunodeficiency virus (HIV). Testing to determine possible infection status is not required.
Immunocompromised patients, e.g., patients who are known to be serologically positive for human immunodeficiency virus (HIV); HIV-positive patients on combination antiretroviral therapy are ineligible
Immunocompromised patients e.g., patients who are known to be serologically positive for human immunodeficiency virus (HIV)
Serologically positive human immunodeficiency virus (HIV) (testing required during screening)
Immunocompromised patients, e.g., patients who are known to be serologically positive for human immunodeficiency virus (HIV).
Known or suspected human immunodeficiency virus (HIV) or serologically positive
Immunocompromised subjects, e.g., subjects who are known to be serologically positive for human immunodeficiency virus;
Known or suspected human immunodeficiency virus (HIV) or serologically positive
Patients who are serologically true-positive for human immunodeficiency virus (HIV)
Patients who are known to be serologically positive for human immunodeficiency virus (HIV) and are receiving antiviral therapy